Table 4.
Illicit drugs reported by participants
| Substance | LBW | National Women | P value* | |
| n | % | % | ||
| Cannabis | 242 | (26.4) | (8.3) | < 0.001 |
| Meth/amphetamine | 171 | (18.6) | (2.5) | < 0.001 |
| Ecstasy | 164 | (17.9) | (2.4) | < 0.001 |
| Cocaine | 60 | (6.5) | (0.8) | < 0.001 |
| Amyl nitrite (poppers) | 39 | (4.3) | n/a | |
| LSD/hallucinogens | 34 | (3.7) | n/a | |
| Dexamphetamine | 17 | (1.9) | n/a | |
| Ketamine | 9 | (1.0) | n/a | |
| Heroin | 9 | (1.0) | (0.1) | < 0.001 |
| Gamma hydroxybutyrate (GHB) | 8 | (0.9) | n/a | |
| Steroids (non-prescribed) | 8 | (0.9) | n/a | |
| Other non-prescribed drug | 21 | (2.3) | n/a | |
| Any illicit drug use | 308 | (33.6) | (12.5) | < 0.001 |
| Any injecting drug use | 32 | (3.5) | (0.3) | < 0.001 |
Notes: Illicit substances reported by LBW in the previous six months, and substance use reported by women in the national population as a whole in the previous 12 months in 2004 [21].
Individuals who reported the use of either speed or crystal methamphetamine are combined in the meth/amphetamine category.
* One-sample Z test.